- Report
- September 2025
- 138 Pages
Global
From €5332EUR$5,950USD£4,575GBP
- Report
- December 2025
- 120 Pages
Global
From €5332EUR$5,950USD£4,575GBP
- Report
- April 2026
- 135 Pages
Global
From €2688EUR$2,999USD£2,306GBP
€3584EUR$3,999USD£3,075GBP
- Report
- January 2026
- 188 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- June 2026
- 189 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- June 2026
- 197 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- June 2026
- 199 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- June 2026
- 188 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- June 2026
- 184 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- January 2026
- 193 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- November 2025
- 188 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- July 2026
- 187 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- July 2026
- 196 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- May 2026
- 185 Pages
Global
From €4033EUR$4,500USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP

The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more